These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34822776)

  • 1. Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2.
    Wu H; Xing N; Meng K; Fu B; Xue W; Dong P; Tang W; Xiao Y; Liu G; Luo H; Zhu W; Lin X; Meng G; Zhu Z
    Cell Host Microbe; 2021 Dec; 29(12):1788-1801.e6. PubMed ID: 34822776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.
    Rahman MS; Islam MR; Alam ASMRU; Islam I; Hoque MN; Akter S; Rahaman MM; Sultana M; Hossain MA
    J Med Virol; 2021 Apr; 93(4):2177-2195. PubMed ID: 33095454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load.
    Mourier T; Shuaib M; Hala S; Mfarrej S; Alofi F; Naeem R; Alsomali A; Jorgensen D; Subudhi AK; Ben Rached F; Guan Q; Salunke RP; Ooi A; Esau L; Douvropoulou O; Nugmanova R; Perumal S; Zhang H; Rajan I; Al-Omari A; Salih S; Shamsan A; Al Mutair A; Taha J; Alahmadi A; Khotani N; Alhamss A; Mahmoud A; Alquthami K; Dageeg A; Khogeer A; Hashem AM; Moraga P; Volz E; Almontashiri N; Pain A
    Nat Commun; 2022 Feb; 13(1):601. PubMed ID: 35105893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity.
    Shuaib M; Adroub S; Mourier T; Mfarrej S; Zhang H; Esau L; Alsomali A; Alofi FS; Ahmad AN; Shamsan A; Khogeer A; Hashem AM; Almontashiri NAM; Hala S; Pain A
    Genome Med; 2023 Jul; 15(1):54. PubMed ID: 37475040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.
    Benvenuto D; Demir AB; Giovanetti M; Bianchi M; Angeletti S; Pascarella S; Cauda R; Ciccozzi M; Cassone A
    J Med Virol; 2020 Oct; 92(10):2232-2237. PubMed ID: 32492183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
    Johnson BA; Zhou Y; Lokugamage KG; Vu MN; Bopp N; Crocquet-Valdes PA; Kalveram B; Schindewolf C; Liu Y; Scharton D; Plante JA; Xie X; Aguilar P; Weaver SC; Shi PY; Walker DH; Routh AL; Plante KS; Menachery VD
    bioRxiv; 2022 Mar; ():. PubMed ID: 34671771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
    Johnson BA; Zhou Y; Lokugamage KG; Vu MN; Bopp N; Crocquet-Valdes PA; Kalveram B; Schindewolf C; Liu Y; Scharton D; Plante JA; Xie X; Aguilar P; Weaver SC; Shi PY; Walker DH; Routh AL; Plante KS; Menachery VD
    PLoS Pathog; 2022 Jun; 18(6):e1010627. PubMed ID: 35728038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America.
    Franco-Muñoz C; Álvarez-Díaz DA; Laiton-Donato K; Wiesner M; Escandón P; Usme-Ciro JA; Franco-Sierra ND; Flórez-Sánchez AC; Gómez-Rangel S; Rodríguez-Calderon LD; Barbosa-Ramirez J; Ospitia-Baez E; Walteros DM; Ospina-Martinez ML; Mercado-Reyes M
    Infect Genet Evol; 2020 Nov; 85():104557. PubMed ID: 32950697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2.
    Nguyen A; Zhao H; Myagmarsuren D; Srinivasan S; Wu D; Chen J; Piszczek G; Schuck P
    Elife; 2024 Jun; 13():. PubMed ID: 38941236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System.
    Raheja H; Das S; Banerjee A; P D; C D; Mukhopadhyay D; Ramachandra SG; Das S
    Microbiol Spectr; 2022 Aug; 10(4):e0078122. PubMed ID: 35862952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms.
    Barona-Gómez F; Delaye L; Díaz-Valenzuela E; Plisson F; Cruz-Pérez A; Díaz-Sánchez M; García-Sepúlveda CA; Sanchez-Flores A; Pérez-Abreu R; Valencia-Valdespino FJ; Vega-Magaña N; Muñoz-Valle JF; García-González OP; Bernal-Silva S; Comas-García A; Cibrián-Jaramillo A
    Microb Genom; 2021 Nov; 7(11):. PubMed ID: 34846283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 mutations: the biological trackway towards viral fitness.
    Majumdar P; Niyogi S
    Epidemiol Infect; 2021 Apr; 149():e110. PubMed ID: 33928885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ongoing global and regional adaptive evolution of SARS-CoV-2.
    Rochman ND; Wolf YI; Faure G; Mutz P; Zhang F; Koonin EV
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34292871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights.
    Kadam SB; Sukhramani GS; Bishnoi P; Pable AA; Barvkar VT
    J Basic Microbiol; 2021 Mar; 61(3):180-202. PubMed ID: 33460172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
    Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
    Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.
    Jacob JJ; Vasudevan K; Pragasam AK; Gunasekaran K; Veeraraghavan B; Mutreja A
    mBio; 2021 Aug; 12(4):e0118821. PubMed ID: 34281387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of intercontinents mutation hotspots and conserved domains within SARS-CoV-2 genome.
    Omotoso OE; Olugbami JO; Gbadegesin MA
    Infect Genet Evol; 2021 Dec; 96():105097. PubMed ID: 34606987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.